In a decisive move to uphold ethical standards and prioritize patient care, the Directorate General of Health Services (DGHS) has issued a directive banning the entry of medical representatives (MRs) into central government hospitals across India. This policy, effective from May 28, aims to prevent undue influence on doctors and promote transparency in prescribing practices. The directive mandates that any updates from pharmaceutical companies should be shared digitally, rather than through in-person interactions on hospital premises.
The practice of MRs frequently visiting doctors in hospitals, often during working hours, has long raised ethical and professional concerns. Such interactions, though seemingly innocuous, can influence prescription choices—sometimes leading to the prioritization of branded drugs over equally effective and more affordable generics. This compromises not only the integrity of medical decisions but also the financial burden on patients, particularly in government hospitals where many seek treatment due to limited means.
The situation in Jammu & Kashmir mirrors the same concerns. In several government hospitals across the Union Territory, it is a common sight to witness MRs meeting doctors in corridors, chambers, and even wards. These meetings, often under the guise of sharing medical updates, are in reality promotional in nature and have the potential to shift the focus away from patient-centric care to profit-driven choices.
Given this backdrop, it is imperative that the Health & Medical Education Department of J&K takes a proactive stance. The DGHS order must serve as a model for immediate adoption in our hospitals. A comprehensive policy banning in-person visits by MRs should be issued without delay. Additionally, institutional heads across J&K must be directed to enforce strict compliance and submit regular reports on the implementation of this policy.
Moreover, hospitals in J&K should establish a digital communication channel—perhaps a centralized portal—where pharmaceutical companies can submit research updates, clinical advancements, and new drug introductions. These can be reviewed periodically by designated committees comprising medical experts, who can then decide what information is relevant and ethically acceptable to share with practitioners.
Medical ethics, impartiality, and patient welfare must remain at the heart of public healthcare. The time has come for present Jammu & Kashmir Government headed by the Chief Minister Omar Abdullah to align with national standards and eliminate practices that risk undermining trust in the system. Banning in-person interactions of MRs with doctors within government hospital premises is not just a policy reform—it is a moral imperative.
